Cytarabine/Hydrocortisone/Methotrexate Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cytarabine, hydrocortisone, and methotrexate that may be used in the treatment and prevention of central nervous system (CNS) involvement in leukemias and lymphomas, including acute promyelocytic leukemia (APL), diffuse large B-cell lymphoma (DLBCL), and acute lymphoblastic leukemia (ALL).

**Synonyms:** - ARA-C/HC/MTX - Cytarabine-Hydrocortisone-Methotrexate - Cytarabine/Hydrocortisone/Methotrexate - MHA - TIT